Breathing Life into the COPD Market: Opportunity for Novel Dual-Action Therapies

ISSN： 1176-3469

Source： Pharmaceutical & Diagnostic Innovation, Vol.3, Iss.4, 2005-04, pp. : 9-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Strategies for Novel COPD Therapies

By Barnes P.J.

Pulmonary Pharmacology & Therapeutics, Vol. 12, Iss. 2, 1999-04 ,pp. : 67-71

Academic Press

Access to resources Recommend Favorite

Breathing Easier: The US Market for Asthma Therapies

Pharmaceutical Innovation, Vol. 11, Iss. 6, 2002-10 ,pp. : 2-9

Adis International

Access to resources Recommend Favorite

Recombination and functional studies of a dual-action peptide for diabetes

By Zheng Jie

Journal of Drug Targeting, Vol. 21, Iss. 5, 2013-05 ,pp. : 443-449

Informa Healthcare

Access to resources Recommend Favorite

Synthesis and antibacterial activity of dual-action agents of a -lactam antibiotic with cytotoxic agent mitozolomide or temozolomide

By Wang Y. Lambert P. Zhao L. Wang D.

European Journal of Medicinal Chemistry, Vol. 37, Iss. 4, 2002-04 ,pp. : 323-332

Elsevier

Access to resources Recommend Favorite

Novel therapy for COPD

By Hansel T.T. Leckie M.J. Bryan S.A. Barnes P.J.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 1, 2000-01 ,pp. : 3-23

Informa Healthcare

Access to resources Recommend Favorite